Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

XAIR – Beyond Air Inc

Beyond Air, Inc.
XAIR
$0.1725
Name : Beyond Air, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $16,007,103.00
EPSttm : -0.69
finviz dynamic chart for XAIR
Beyond Air, Inc.
$0.1725
7.72%
$0.0125

Float Short %

4.26

Margin Of Safety %

Put/Call OI Ratio

0.01

EPS Next Q Diff

0.09

EPS Last/This Y

0.69

EPS This/Next Y

Price

0.16

Target Price

2.25

Analyst Recom

1

Performance Q

-43.08

Relative Volume

0.88

Beta

0.22

Ticker: XAIR




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02XAIR0.18330.014.295044
2025-06-03XAIR0.18570.011.085053
2025-06-04XAIR0.18710.010.005076
2025-06-05XAIR0.18250.010.005082
2025-06-06XAIR0.18710.010.005089
2025-06-09XAIR0.1860.010.015092
2025-06-10XAIR0.19660.010.005160
2025-06-11XAIR0.1980.010.005408
2025-06-12XAIR0.18320.010.015434
2025-06-13XAIR0.17890.010.085561
2025-06-16XAIR0.180.010.005609
2025-06-17XAIR0.29110.010.016118
2025-06-18XAIR0.20380.010.028147
2025-06-20XAIR0.22890.010.078372
2025-06-23XAIR0.18640.000.127552
2025-06-24XAIR0.18390.010.137542
2025-06-25XAIR0.17110.013.437553
2025-06-26XAIR0.16420.010.737567
2025-06-27XAIR0.16680.010.337644
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02XAIR0.18- - 0.00
2025-06-03XAIR0.19- - 0.00
2025-06-04XAIR0.19- - 0.00
2025-06-05XAIR0.18- - 0.00
2025-06-06XAIR0.19- - 0.00
2025-06-09XAIR0.19- - 0.00
2025-06-10XAIR0.20- - 0.00
2025-06-11XAIR0.20- - 0.00
2025-06-12XAIR0.18- - 0.00
2025-06-13XAIR0.18- - 0.00
2025-06-16XAIR0.18- - 0.00
2025-06-17XAIR0.28- - 0.00
2025-06-18XAIR0.20- - 0.00
2025-06-20XAIR0.23- - 0.00
2025-06-23XAIR0.19- - 0.00
2025-06-24XAIR0.18- - 0.00
2025-06-25XAIR0.17- - 0.00
2025-06-26XAIR0.16- - 0.00
2025-06-27XAIR0.16- - 0.00
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




18 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02XAIR9.94-6.263.64
2025-06-03XAIR9.94-6.263.64
2025-06-04XAIR9.94-6.263.64
2025-06-05XAIR9.94-6.263.64
2025-06-06XAIR9.94-6.263.64
2025-06-09XAIR9.94-6.263.64
2025-06-11XAIR9.94-6.263.49
2025-06-12XAIR9.94-6.263.49
2025-06-13XAIR9.94-6.263.49
2025-06-16XAIR9.94-6.263.49
2025-06-17XAIR9.94-6.263.49
2025-06-18XAIR9.94-6.263.49
2025-06-19XAIR9.94-6.263.49
2025-06-20XAIR9.94-6.263.49
2025-06-24XAIR9.94-6.263.49
2025-06-25XAIR9.19-6.263.25
2025-06-26XAIR9.19-6.264.26
2025-06-27XAIR9.19-6.264.26
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
18 items Current Page1 of 1

Last Quarter Act. EPS

-0.09

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

9.19

Institutional Transactions

-6.26

Beta

0.22

Average Sales Estimate Current Quarter

1

Average Sales Estimate Next Quarter

2

Fair Value

Quality Score

17

Growth Score

39

Sentiment Score

2

Actual DrawDown %

99

Max Drawdown 5-Year %

-99

Target Price

2.25

P/E

Forward P/E

PEG

P/S

4

P/B

0.97

P/Free Cash Flow

EPS

-0.79

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-1258.46

Relative Volume

0.88

Return on Equity vs Sector %

-367.2

Return on Equity vs Industry %

-361.7

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Beyond Air, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 61
Beyond Air, Inc., a commercial-stage medical device and biopharmaceutical company, develops the Lungfit platform, a nitric oxide (NO) generator and delivery system platform. It operates through three segments: Beyond Air, Beyond Cancer, and NeuroNos. The company offers Lungfit PH for the treatment of persistent pulmonary hypertension of the newborn. It is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired pneumonia, including COVID-19 and bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria (NTM) at home. In addition, the company develops ultra-high concentration (UNO) that is in Phase 1 clinical trial to treat multiple solid and cutaneous tumors; and selective neuronal nitric oxide synthase (nNOS) inhibitor for the treatment of neurological conditions and autism spectrum disorder. It has a collaboration with the Yissum Research Development Company of the Hebrew University of Jerusalem, LTD to acquire the commercial rights for neuronal nitric oxide synthase inhibitors to treat autism spectrum disorder and other neurological conditions. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. was founded in 2011 and is headquartered in Garden City, New York.
stock quote shares XAIR – Beyond Air Inc Stock Price stock today
news today XAIR – Beyond Air Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch XAIR – Beyond Air Inc yahoo finance google finance
stock history XAIR – Beyond Air Inc invest stock market
stock prices XAIR premarket after hours
ticker XAIR fair value insiders trading